权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Non Human Primate Core

非人类灵长类核心

基本信息

批准号：
10619299
负责人：
Michael K Axthelm
金额：
$ 148.9万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-09-22 至 2027-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10619299
关键词：
Animal Housing Animal Model Animals Autopsy CD8-Positive T-Lymphocytes Cells Clinical Clinical Data Clinical Management Communicable Diseases Complex Data Data Analyses Data Collection Elements Ensure Epitopes Event Goals HIV-1 Human Human Resources Immune Immunize Immunologics Infection Infrastructure Intercept Interleukin-15 Investigation Lead Leadership Macaca mulatta Mediating Mission Modeling Pathologic Performance Physiological Procedures Program Research Project Grants Protocols documentation Quality Control Records Research Research Personnel Risk Role SIV SIV Vaccines Safety Sampling Signal Transduction Specimen Handling Structure Supervision T-Lymphocyte Technical Expertise Tissues Vaccination Viral Virus Diseases Virus Replication Work efficacy evaluation efficacy research experience experimental study in vivo nonhuman primate novel programs response sample collection simian human immunodeficiency virus transcriptomics vector virtual

项目摘要

CORE B SUMMARY The Nonhuman Primate (NHP) Core seeks to consolidate supervision and performance of the NHP experimental protocols of the Program Project entitled “Immunologic and virologic basis of RhCMV/SIV vaccine-induced replication arrest efficacy” into a structured Core composed of highly experienced research personnel. The global objective of the Core is to provide leadership and technical expertise to ensure consistency and quality control in animal selection, execution of study protocols, application of experimental procedures, animal observations and data collection necessary to meet the objectives of Project and other Core lead investigators. To accomplish this, the Core will manage and directly supervise all NHP studies for the Project including: 1) animal selection; 2) animal housing and general husbandry; 3) experimental procedures and clinical management; 4) specimen collection and processing; 5) necropsy studies; and 6) acquisition and management of animal demographic, physiologic, clinical, and pathologic data. The overall objective of the Program Project is to determine the mechanisms responsible for complete arrest and subsequent clearance of nascent SIV infection in RhCMV/SIV- immunized rhesus macaques, including the requirement for MHC-E restricted epitope recognition for efficacy, how cells mediate replication arrest and the role of IL-15 signaling identified as a predictive transcriptomic signature. The NHP Core will provide the expertise and technical support required to insure successful completion of the multifaceted and extensive NHP research protocols supporting Project 1 – Immunologic and virologic characterization of RhCMV/SIV vaccine-mediated SIV “replication arrest” efficacy, Project 2 – Characterization of the in vivo T cell (and overall immune) interception of primary SIV infection after vaccination with differentially response programmed RhCMV/SIV vectors (MHC-E vs. MHC-II vs. MHC-Ia) and a conventional SIV vaccine, and Project 3 – Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV “replication arrest” efficacy.

核心b概述